Pathologic Residual Cancer Cells
1 clinical trials · Condition
◉ Watch Pathologic Residual Cancer Cells
| Record | Firm | Date |
|---|---|---|
| Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy (NCT03703427) | Zhiyong Yu | 2018-11-01 |
Track Pathologic Residual Cancer Cells automatically
Every clearance here is in the API, with alerts when new ones post.